Drug or technology
9 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 9, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is a Phase 1, first-in-human study registration with no results posted; it describes planned enrollment and safety endpoints only, representing early-stage drug development.
SEP 8, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a Phase 3 RCT registration with no results posted; the study is actively recruiting and designed to test a novel PIK3CA inhibitor in advanced breast cancer, but outcome data are not yet available.
AUG 20, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 dose-escalation study with safety endpoints only; no efficacy results reported in registry record. Designed to establish recommended dose of [177Lu]Lu-NeoB in combination therapy.
AUG 18, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for assessment.
AUG 17, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a registry record for an actively recruiting Phase 1b/3 trial with no results posted; it describes study design and planned enrollment only.
AUG 13, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a completed prospective observational registry study with no results posted; it describes treatment patterns and outcomes in routine practice but carries no efficacy or safety data in this record.
AUG 11, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is an actively recruiting Phase 2 trial with no results posted; the registry record describes design and planned endpoints only, not outcomes.
AUG 10, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
Phase IIIb registration record with no results posted; describes planned enrollment and primary outcome measure only, without efficacy or safety data.